250 filings
10-Q
2024 Q1
CARA
Cara Therapeutics Inc
Quarterly report
13 May 24
4:17pm
8-K
CARA
Cara Therapeutics Inc
13 May 24
Cara Therapeutics Reports First Quarter 2024 Financial Results
4:10pm
DEFA14A
CARA
Cara Therapeutics Inc
22 Apr 24
Additional proxy soliciting materials
4:08pm
ARS
2023 FY
CARA
Cara Therapeutics Inc
22 Apr 24
Annual report to shareholders
4:07pm
DEF 14A
CARA
Cara Therapeutics Inc
Definitive proxy
22 Apr 24
4:05pm
PRE 14A
bjw2 rzo55deo8
12 Apr 24
Preliminary proxy
4:15pm
8-K
pqvpm7etkh9uxxp2i
22 Mar 24
Departure of Directors or Certain Officers
4:05pm
S-8
z9ep9 yckto911ygvg1
6 Mar 24
Registration of securities for employees
4:45pm
8-K
qe093rck
4 Mar 24
Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
4:10pm
8-K
5x9j 69bdro0z
2 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:59pm
8-K
momyezbr 7u0l
22 Jan 24
Cost Associated with Exit or Disposal Activities
4:19pm
8-K
3zopz9 odeo
18 Dec 23
Regulation FD Disclosure
7:10am
8-K
ff46ev
13 Nov 23
Corporate Presentation November 2023
4:28pm
8-K
jxiebc0sps7v 5fb
13 Nov 23
Cara Therapeutics Reports Third Quarter 2023 Financial Results
4:11pm
8-K
qzldg
2 Nov 23
Cara Therapeutics Announces up to $40.0 Million Non-Dilutive Financing Agreement with HealthCare Royalty
7:10am
8-K
kmne2igctd
7 Aug 23
Corporate Presentation August 2023
4:24pm
8-K
7zm9nepa s7lf15
7 Aug 23
Cara Therapeutics Reports Second Quarter 2023 Financial Results
4:10pm